{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:59:56Z","timestamp":1789181996935,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2017.10.011","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T22:14:27Z","timestamp":1516140867000},"page":"7381-7390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["WHO consultation on ETEC and Shigella burden of disease, Geneva, 6\u20137th April 2017: Meeting report"],"prefix":"10.1016","volume":"37","author":[{"given":"Divya","family":"Hosangadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte K.","family":"Giersing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.011_b0005","unstructured":"Estimates of global regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis; 2017."},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.011_b0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review","volume":"74","author":"Riddle","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.011_b0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","article-title":"Global etiology of travelers' diarrhea: systematic review from 1973 to the present","volume":"80","author":"Shah","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.10.011_b0020","unstructured":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1459\u2013544."},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.011_b0025","doi-asserted-by":"crossref","first-page":"e72788","DOI":"10.1371\/journal.pone.0072788","article-title":"Global causes of diarrheal disease mortality in children <5 years of age: a systematic review","volume":"8","author":"Lanata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.10.011_b0030","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2013; 88(10053): 1545\u2013602."},{"key":"10.1016\/j.vaccine.2017.10.011_b0035","unstructured":"W.H. Organization. The treatment of diarrhoea a manual for physicians and other senior health workers; 2005. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/43209\/1\/9241593180.pdf>."},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2017.10.011_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw090","article-title":"Resistant pathogens as causes of traveller's diarrhea globally and impact(s) on treatment failure and recommendations","volume":"24","author":"Tribble","year":"2017","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.011_b0045","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/AAC.00739-10","article-title":"In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008","volume":"55","author":"Ouyang-Latimer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2017.10.011_b0050","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385(9963): 117\u201371.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"issue":"10051","key":"10.1016\/j.vaccine.2017.10.011_b0055","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"9859","key":"10.1016\/j.vaccine.2017.10.011_b0060","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.011_b0065","doi-asserted-by":"crossref","first-page":"e0142927","DOI":"10.1371\/journal.pone.0142927","article-title":"Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food","volume":"10","author":"Pires","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.011_b0070","doi-asserted-by":"crossref","first-page":"e1001921","DOI":"10.1371\/journal.pmed.1001921","article-title":"World health organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis","volume":"12","author":"Kirk","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.011_b0075","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1371\/journal.pntd.0002705","article-title":"Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa","volume":"8","author":"Lamberti","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"9888","key":"10.1016\/j.vaccine.2017.10.011_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.011_b0085","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.011_b0090","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2214-109X(15)00052-2","article-title":"Community-acquired diarrhoea in a world with rotavirus vaccine: a glimpse into the future","volume":"3","author":"Neuzil","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2017.10.011_b0095","unstructured":"GAVI Vaccine Investment Strategy, <http:\/\/who.int\/immunization\/research\/meetings_workshops\/20_Gavi_presentation.pdf>."},{"key":"10.1016\/j.vaccine.2017.10.011_b0100","unstructured":"WHO\u2019s Preferred Product Characteristics (PPCs) and Target Product Profiles (TPPs); 2017. <http:\/\/www.who.int\/immunization\/research\/ppc-tpp\/en\/>."},{"issue":"10062","key":"10.1016\/j.vaccine.2017.10.011_b0105","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.10.011_b0110","unstructured":"W.H. Organization. New checklist to make health estimates more transparent, accurate and reliable; June 2016. <http:\/\/www.who.int\/features\/2016\/gather-health-estimates\/en\/>."},{"key":"10.1016\/j.vaccine.2017.10.011_b0115","doi-asserted-by":"crossref","unstructured":"Colombara DK, Khalil I, Rao P, et al. Chronic health consequences of acute enteric infections in the developing world. Am J Gastroenterol Suppl 2016; 3: 4\u20139.","DOI":"10.1038\/ajgsup.2016.9"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.011_b0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.pcl.2017.03.006","article-title":"The burden and etiology of diarrheal illness in developing countries","volume":"64","author":"Kotloff","year":"2017","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.011_b0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1753-4887.2008.00082.x","article-title":"Malnutrition as an enteric infectious disease with long-term effects on child development","volume":"66","author":"Guerrant","year":"2008","journal-title":"Nutr Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.011_b0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ije\/dyn099","article-title":"Multi-country analysis of the effects of diarrhoea on childhood stunting","volume":"37","author":"Checkley","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.10.011_b0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jix294","article-title":"Etiology of severe acute watery diarrhea in children in the global rotavirus surveillance network using quantitative polymerase chain reaction","volume":"216","author":"Operario","year":"2017","journal-title":"J Infect Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.011_b0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QCO.0000000000000096","article-title":"Global burden of childhood diarrhea and interventions","volume":"27","author":"Das","year":"2014","journal-title":"Curr Opin Infect Dis"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2017.10.011_b0145","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1177\/15648265150361S113","article-title":"Environmental enteric dysfunction: an overview","volume":"36","author":"Crane","year":"2015","journal-title":"Food Nutr Bull"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.011_b0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrgastro.2012.239","article-title":"The impoverished gut\u2013a triple burden of diarrhoea, stunting and chronic disease","volume":"10","author":"Guerrant","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2017.10.011_b0155","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1016\/j.vaccine.2017.05.035","article-title":"Chronic consequences on human health induced by microbial pathogens: growth faltering among children in developing countries","volume":"35","author":"Nataro","year":"2017","journal-title":"Vaccine"},{"issue":"9609","key":"10.1016\/j.vaccine.2017.10.011_b0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(07)61692-4","article-title":"Maternal and child undernutrition: consequences for adult health and human capital","volume":"371","author":"Victora","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2017.10.011_b0165","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/aje\/kwt094","article-title":"Diarrhea in early childhood: short-term association with weight and long-term association with length","volume":"178","author":"Richard","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.011_b0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2012.12-0549","article-title":"Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants","volume":"88","author":"Kosek","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"26","key":"10.1016\/j.vaccine.2017.10.011_b0175","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2016.02.076","article-title":"Status of vaccine research and development for enterotoxigenic Escherichia coli","volume":"34","author":"Bourgeois","year":"2016","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2017.10.011_b0180","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.011_b0185","unstructured":"Administration, U.S.F.a.D. Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies; 1997. <https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/vaccines\/ucm175909.pdf.%202014>."},{"issue":"8","key":"10.1016\/j.vaccine.2017.10.011_b0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.vaccine.2014.11.048","article-title":"Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.011_b0195","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1016\/j.vaccine.2017.06.076","article-title":"Combination vaccine strategies to prevent enteric infections","volume":"35","author":"Walker","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.011_b0200","first-page":"1434","article-title":"Combination vaccines against diarrheal diseases","volume":"11","author":"Venkatesan","year":"2015","journal-title":"Hum Vacc Immunother"},{"issue":"37","key":"10.1016\/j.vaccine.2017.10.011_b0205","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.011_b0210","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.3145","article-title":"Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution","volume":"46","author":"von Mentzer","year":"2014","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.vaccine.2017.10.011_b0215","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2017.10.011_b0220","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.011_b0225","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/CVI.00364-12","article-title":"The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease","volume":"19","author":"Darsley","year":"2012","journal-title":"Clin Vacc Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.011_b0230","doi-asserted-by":"crossref","first-page":"e0149358","DOI":"10.1371\/journal.pone.0149358","article-title":"An evidenced-based scale of disease severity following human challenge with enteroxigenic Escherichia coli","volume":"11","author":"Porter","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.011_b0235","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/IAI.00858-15","article-title":"Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge","volume":"83","author":"Luiz","year":"2015","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.011_b0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.vaccine.2015.11.017","article-title":"Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates","volume":"34","author":"Sincock","year":"2016","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2017.10.011_b0245","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.vaccine.2016.04.003","article-title":"Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA\/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA","volume":"34","author":"Nandre","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.011_b0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vetmic.2016.02.002","article-title":"Antibodies derived from a toxoid MEFA (multiepitope fusion antigen) show neutralizing activities against heat-labile toxin (LT), heat-stable toxins (STa, STb), and Shiga toxin 2e (Stx2e) of porcine enterotoxigenic Escherichia coli (ETEC)","volume":"202","author":"Rausch","year":"2017","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.011_b0255","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/CVI.00608-15","article-title":"Evaluation of the safety, tolerability, and immunogenicity of an oral, inactivated whole-cell shigella flexneri 2a vaccine in healthy adult subjects","volume":"23","author":"Chakraborty","year":"2016","journal-title":"Clin Vacc Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2017.10.011_b0260","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2005.07.014","article-title":"Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial","volume":"24","author":"McKenzie","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.011_b0265","doi-asserted-by":"crossref","unstructured":"Porter C, Kowalcyk, Riddle MR. Chronic Health Consequences of acute enteric infections in the developed world. Am J Gastroenterol Suppl 2016; 3: 12\u201323.","DOI":"10.1038\/ajgsup.2016.10"},{"issue":"24","key":"10.1016\/j.vaccine.2017.10.011_b0270","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.2016.7833","article-title":"Persistent diarrhea: a clinical review","volume":"315","author":"DuPont","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2017.10.011_b0275","unstructured":"Global antimicrobial resistance surveillance system; 2015. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/188783\/1\/9789241549400_eng.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2017.10.011_b0280","unstructured":"Tackling drug-resistant infections globally: final report and recommendations; 2015. <https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:52Z","timestamp":1759402192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":56,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X17313762"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WHO consultation on ETEC and Shigella burden of disease, Geneva, 6\u20137th April 2017: Meeting report","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}